N/A N=7 Treatment

Rapid Non-Invasive Brain Stimulation for OCD (oTMS)

OCD

Bottom Line

View on ClinicalTrials.gov: NCT03404609 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

May 2021

Primary outcome: Primary: Number of Patients Who Met and Exceeded Response Criteria of Yale-Brown Obsessive-Compulsive Scale. — 4 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: MagPro X100 by MagVenture (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Stanford University
Primary completion: Jul 2019

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Patients Who Met and Exceeded Response Criteria of Yale-Brown Obsessive-Compulsive Scale.	4	—

Summary

The purpose of this study is to understand how cortical stimulation affects Obsessive-Compulsive Disorder (OCD) symptoms.

Eligibility Criteria

Inclusion Criteria

Age 18-80
Primary diagnosis of OCD
Sufficient severity of OCD symptoms
Capacity to provide informed consent

Exclusion Criteria

Psychiatric or medical conditions or medications that make participation unsafe
Pregnant or nursing females
Previous exposure to TMS or ECT
History of any implanted device or psychosurgery
Presence of metallic device or dental braces

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03404609). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.